Seres Therapeutics
MCRB
152 hedge funds and large institutions have $1.85B invested in Seres Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 45 reducing their positions, and 23 closing their positions.
606% more call options, than puts
Call options by funds: $35.3M | Put options by funds: $5.01M
36% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 45
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
0.17% more ownership
Funds ownership: 4.74% → 4.92% (+0.17%)
0% more funds holding
Funds holding: 152 → 152 (0)
12% less capital invested
Capital invested by funds: $2.12B → $1.85B (-$264M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$85.1M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$23.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$8.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$43.4M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$14.5M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$13.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.7M |
| 5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$8.82M |
MCRB Hedge Fund Activity: Q1 2021 in Review
152 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Seres Therapeutics (MCRB) for Q1 2021, worth a combined $1.85B — down 12% from $2.12B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new MCRB positions and 23 closed out — a net gain of 2 holders — while 61 added to existing stakes and 45 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $85.1M. The largest seller was ARK Investment Management, cutting an estimated $43.4M.
- 152 institutional investors held Seres Therapeutics (MCRB) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $1.85B of Seres Therapeutics stock for Q1 2021, down 12% quarter-over-quarter.
- 25 funds opened new Seres Therapeutics positions in Q1 2021 and 23 closed out, a net change of +2 holders.
- The largest Seres Therapeutics buyer in Q1 2021 was RA Capital Management, an estimated $85.1M added.
- The largest Seres Therapeutics seller in Q1 2021 was ARK Investment Management, an estimated $43.4M sold.
Based on aggregated 13F filings for Q1 2021.